PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT PART 03: RESEARCH METHODOLOGY PART 04: MARKET LANDSCAPE • Market ecosystem • Market characteristics • Market segmentation analysis PART 05: MARKET SIZING • Market definition • Market sizing 2017 • Market size and forecast 2017-2022 PART 06: FIVE FORCES ANALYSIS • Bargaining power of buyers • Bargaining power of suppliers • Threat of new entrants • Threat of substitutes • Threat of rivalry • Market condition PART 07: MARKET SEGMENTATION BY PRODUCT • Overview • Comparison by product • Implantable neurostimulation devices • External neurostimulation devices • Market opportunity by product PART 08: CUSTOMER LANDSCAPE PART 09: REGIONAL LANDSCAPE • Geographical segmentation • Regional comparison • Americas • EMEA • APAC • Market opportunity PART 10: DECISION FRAMEWORK PART 11: DRIVERS AND CHALLENGES • Market drivers • Market challenges PART 12: MARKET TRENDS • Expanding indications of neurostimulation devices • Increasing number of initiatives that support research related to • neurostimulation technology PART 13: VENDOR LANDSCAPE • Overview • Landscape disruption PART 14: VENDOR ANALYSIS • Vendors covered • Vendor classification • Market positioning of vendors • Abbott • Boston Scientific • LivaNova • Medtronic • Nevro PART 15: APPENDIX • List of abbreviations PART 16: EXPLORE TECHNAVIO   Exhibit 01: Global medical devices market Exhibit 02: Global medical devices market: Segments Exhibit 03: Market characteristics Exhibit 04: Global neurostimulation devices market: Segments Exhibit 05: Market definition: Inclusions and exclusions checklist Exhibit 06: Global neurostimulation devices market: Market size 2017 Exhibit 07: Validation techniques employed for market sizing 2017 Exhibit 08: Global neurostimulation devices market: Market size and forecast 2017-2022 ($ mn) Exhibit 09: Global neurostimulation devices market: Year-over-year growth 2018-2022 (%) Exhibit 10: Five forces analysis 2017 Exhibit 11: Five forces analysis 2022 Exhibit 12: Bargaining power of buyers Exhibit 13: Bargaining power of suppliers Exhibit 14: Threat of new entrants Exhibit 15: Threat of substitutes Exhibit 16: Threat of rivalry Exhibit 17: Market condition: Five forces 2017 Exhibit 18: Segmentation by product: Market share 2017-2022 (%) Exhibit 19: Comparison by product Exhibit 20: Implantable neurostimulation devices: Market size and forecast 2017-2022 ($ mn) Exhibit 21: Implantable neurostimulation devices: Year-over-year growth 2018-2022 (%) Exhibit 22: External neurostimulation devices: Market size and forecast 2017-2022 ($ mn) Exhibit 23: External neurostimulation devices: Year-over-year growth 2018-2022 (%) Exhibit 24: Market opportunity by product Exhibit 25: Customer landscape Exhibit 26: Segmentation by geography: Market share 2017-2022 (%) Exhibit 27: Regional comparison Exhibit 28: Americas: Market size and forecast 2017-2022 ($ mn) Exhibit 29: Americas: Year-over-year growth 2018-2022 (%) Exhibit 30: Top three countries in Americas Exhibit 31: EMEA: Market size and forecast 2017-2022 ($ mn) Exhibit 32: EMEA: Year-over-year growth 2018-2022 (%) Exhibit 33: Top three countries in EMEA Exhibit 34: APAC: Market size and forecast 2017-2022 ($ mn) Exhibit 35: APAC: Year-over-year growth 2018-2022 (%) Exhibit 36: Top three countries in APAC Exhibit 37: Market opportunity Exhibit 38: Vendor landscape Exhibit 39: Landscape disruption Exhibit 40: Vendors covered Exhibit 41: Vendor classification Exhibit 42: Market positioning of vendors Exhibit 43: Abbott: Overview Exhibit 44: Abbott: Business segments Exhibit 45: Abbott: Organizational developments Exhibit 46: Abbott: Geographic focus Exhibit 47: Abbott: Segment focus Exhibit 48: Abbott: Key offerings Exhibit 49: Abbott: Key customers Exhibit 50: Boston Scientific: Overview Exhibit 51: Boston Scientific: Business segments Exhibit 52: Boston Scientific: Organizational developments Exhibit 53: Boston Scientific: Geographic focus Exhibit 54: Boston Scientific: Segment focus Exhibit 55: Boston Scientific: Key offerings Exhibit 56: Boston Scientific: Key customers Exhibit 57: LivaNova: Overview Exhibit 58: LivaNova: Business segments Exhibit 59: LivaNova: Organizational developments Exhibit 60: LivaNova: Geographic focus Exhibit 61: LivaNova: Segment focus Exhibit 62: LivaNova: Key offerings Exhibit 63: LivaNova: Key customers Exhibit 64: Medtronic: Overview Exhibit 65: Medtronic: Business segments Exhibit 66: Medtronic: Organizational developments Exhibit 67: Medtronic: Geographic focus Exhibit 68: Medtronic: Segment focus Exhibit 69: Medtronic: Key offerings Exhibit 70: Medtronic: Key customers Exhibit 71: Nevro: Overview Exhibit 72: Nevro: Business segments Exhibit 73: Nevro: Organizational developments Exhibit 74: Nevro: Geographic focus Exhibit 75: Nevro: Key offerings Exhibit 76: Nevro: Key customers  

Abbott Boston Scientific LivaNova Medtronic and Nevro